- TheStreet.com•10 hours ago
Soliris sales of $783 million in the first quarter benefited from a one-time, $29 million change in revenue recognition but still came in higher than consensus.
- Investor's Business Daily•14 hours ago
Alexion stock popped on Thursday after the top 10 biotech crushed Wall Street's expectations for first-quarter sales and adjusted profits.
- Investor's Business Daily•15 hours ago
AbbVie reported better-than-expected earnings and revenue early Thursday. Shares of the drugmaker traded around a buy point.
ALXN : Summary for Alexion Pharmaceuticals, Inc. - Yahoo Finance
Alexion Pharmaceuticals, Inc. (ALXN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||125.11 x 100|
|Ask||127.00 x 200|
|Day's Range||121.80 - 127.94|
|52 Week Range||109.12 - 157.02|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||72.06|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|